Product Code: ETC4746673 | Publication Date: Nov 2023 | Updated Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
The Gabon Influenza Vaccine Market is projected to witness mixed growth rate patterns during 2025 to 2029. The growth rate begins at 3.97% in 2025, climbs to a high of 5.78% in 2028, and moderates to 4.70% by 2029.
The Influenza Vaccine market in Gabon is projected to grow at a growing growth rate of 5.62% by 2027, highlighting the country's increasing focus on advanced technologies within the Africa region, where Egypt holds the dominant position, followed closely by South Africa, Ethiopia, Algeria and Nigeria, shaping overall regional demand.
The influenza vaccine market in Gabon is essential as the government and health organizations focus on improving public health and controlling influenza outbreaks. Vaccination campaigns are vital in preventing seasonal flu and reducing healthcare burdens. With the increasing awareness of health risks and the impact of flu on vulnerable populations, the demand for influenza vaccines is expected to rise. Additionally, global health concerns such as the COVID-19 pandemic have further highlighted the importance of vaccines, prompting further investments in immunization programs in Gabon.
The Gabon Influenza Vaccine market is growing due to the rising awareness of health risks associated with seasonal flu and the need for preventive healthcare measures. The government and healthcare institutions are increasingly investing in vaccination campaigns to combat influenza outbreaks. Additionally, the global emphasis on health and wellness, especially in the wake of the COVID-19 pandemic, has contributed to the demand for flu vaccines in Gabon.
The Gabon Influenza Vaccine market struggles with challenges such as limited healthcare infrastructure, which impacts the distribution and administration of vaccines. Additionally, the market is impacted by a lack of awareness and education about the importance of influenza vaccination, particularly in rural areas. The high cost of vaccines, along with logistical challenges in storage and transportation, further restricts access to vaccines. Furthermore, the reliance on imported vaccines creates vulnerabilities in supply chains, making timely delivery difficult.
Gabons healthcare policies, particularly those addressing public health concerns and epidemic preparedness, support the influenza vaccine market. Government investments in healthcare infrastructure and vaccination campaigns, especially for rural populations, drive demand for vaccines.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Gabon Influenza Vaccine Market Overview |
3.1 Gabon Country Macro Economic Indicators |
3.2 Gabon Influenza Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Gabon Influenza Vaccine Market - Industry Life Cycle |
3.4 Gabon Influenza Vaccine Market - Porter's Five Forces |
3.5 Gabon Influenza Vaccine Market Revenues & Volume Share, By Vaccine type, 2021 & 2031F |
3.6 Gabon Influenza Vaccine Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Gabon Influenza Vaccine Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.8 Gabon Influenza Vaccine Market Revenues & Volume Share, By Age Group, 2021 & 2031F |
3.9 Gabon Influenza Vaccine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
4 Gabon Influenza Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Gabon Influenza Vaccine Market Trends |
6 Gabon Influenza Vaccine Market Segmentations |
6.1 Gabon Influenza Vaccine Market, By Vaccine type |
6.1.1 Overview and Analysis |
6.1.2 Gabon Influenza Vaccine Market Revenues & Volume, By Quadrivalent, 2021-2031F |
6.1.3 Gabon Influenza Vaccine Market Revenues & Volume, By Trivalent, 2021-2031F |
6.2 Gabon Influenza Vaccine Market, By Type |
6.2.1 Overview and Analysis |
6.2.2 Gabon Influenza Vaccine Market Revenues & Volume, By Seasonal, 2021-2031F |
6.2.3 Gabon Influenza Vaccine Market Revenues & Volume, By Pandemic, 2021-2031F |
6.3 Gabon Influenza Vaccine Market, By Technology |
6.3.1 Overview and Analysis |
6.3.2 Gabon Influenza Vaccine Market Revenues & Volume, By Egg-based, 2021-2031F |
6.3.3 Gabon Influenza Vaccine Market Revenues & Volume, By Cell-based, 2021-2031F |
6.4 Gabon Influenza Vaccine Market, By Age Group |
6.4.1 Overview and Analysis |
6.4.2 Gabon Influenza Vaccine Market Revenues & Volume, By Pediatric, 2021-2031F |
6.4.3 Gabon Influenza Vaccine Market Revenues & Volume, By Adult, 2021-2031F |
6.5 Gabon Influenza Vaccine Market, By Route of Administration |
6.5.1 Overview and Analysis |
6.5.2 Gabon Influenza Vaccine Market Revenues & Volume, By Injection, 2021-2031F |
6.5.3 Gabon Influenza Vaccine Market Revenues & Volume, By Nasal Spray, 2021-2031F |
7 Gabon Influenza Vaccine Market Import-Export Trade Statistics |
7.1 Gabon Influenza Vaccine Market Export to Major Countries |
7.2 Gabon Influenza Vaccine Market Imports from Major Countries |
8 Gabon Influenza Vaccine Market Key Performance Indicators |
9 Gabon Influenza Vaccine Market - Opportunity Assessment |
9.1 Gabon Influenza Vaccine Market Opportunity Assessment, By Vaccine type, 2021 & 2031F |
9.2 Gabon Influenza Vaccine Market Opportunity Assessment, By Type, 2021 & 2031F |
9.3 Gabon Influenza Vaccine Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.4 Gabon Influenza Vaccine Market Opportunity Assessment, By Age Group, 2021 & 2031F |
9.5 Gabon Influenza Vaccine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
10 Gabon Influenza Vaccine Market - Competitive Landscape |
10.1 Gabon Influenza Vaccine Market Revenue Share, By Companies, 2024 |
10.2 Gabon Influenza Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |